JP2016510765A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510765A5 JP2016510765A5 JP2015561747A JP2015561747A JP2016510765A5 JP 2016510765 A5 JP2016510765 A5 JP 2016510765A5 JP 2015561747 A JP2015561747 A JP 2015561747A JP 2015561747 A JP2015561747 A JP 2015561747A JP 2016510765 A5 JP2016510765 A5 JP 2016510765A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- steroid
- halogen
- prednisolone
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/791,685 US9012432B2 (en) | 2013-03-08 | 2013-03-08 | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
| US13/791,685 | 2013-03-08 | ||
| PCT/US2014/022169 WO2014138712A1 (en) | 2013-03-08 | 2014-03-07 | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071500A Division JP2019104762A (ja) | 2013-03-08 | 2019-04-03 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510765A JP2016510765A (ja) | 2016-04-11 |
| JP2016510765A5 true JP2016510765A5 (enExample) | 2017-04-06 |
| JP6839491B2 JP6839491B2 (ja) | 2021-03-17 |
Family
ID=51488530
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561747A Expired - Fee Related JP6839491B2 (ja) | 2013-03-08 | 2014-03-07 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
| JP2019071500A Pending JP2019104762A (ja) | 2013-03-08 | 2019-04-03 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071500A Pending JP2019104762A (ja) | 2013-03-08 | 2019-04-03 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9012432B2 (enExample) |
| EP (1) | EP2964209B1 (enExample) |
| JP (2) | JP6839491B2 (enExample) |
| KR (1) | KR102253394B1 (enExample) |
| CN (1) | CN105324113B (enExample) |
| AU (1) | AU2014225373B2 (enExample) |
| BR (1) | BR112015021503B1 (enExample) |
| CA (1) | CA2941346C (enExample) |
| EA (1) | EA032067B1 (enExample) |
| ES (1) | ES2904365T3 (enExample) |
| MX (1) | MX377447B (enExample) |
| WO (1) | WO2014138712A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017155233A1 (ko) | 2016-03-09 | 2017-09-14 | 주식회사 바이오펩 | 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도 |
| US10913772B2 (en) | 2016-03-09 | 2021-02-09 | Kine Sciences Co., Ltd. | Peptide for preventing or treating inflammatory diseases and use thereof |
| US10913771B2 (en) | 2016-03-09 | 2021-02-09 | Kine Sciences Co., Ltd. | Peptide for preventing or treating inflammatory diseases and use thereof |
| WO2017155234A1 (ko) | 2016-03-09 | 2017-09-14 | 주식회사 바이오펩 | 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도 |
| KR101897122B1 (ko) | 2016-03-09 | 2018-09-10 | 주식회사 바이오펩 | 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도 |
| JP7127616B2 (ja) | 2019-06-04 | 2022-08-30 | 横河電機株式会社 | 情報処理装置、アラーム管理システム、及びアラーム管理方法 |
| WO2021163432A1 (en) * | 2020-02-12 | 2021-08-19 | Levolta Pharmaceuticals, Inc. | Co-administration of prednisolone/methyl prednisolone and zoledronic acid to treat and prevent osteoarthritis |
| CN114028571B (zh) * | 2021-11-18 | 2023-04-28 | 中国医学科学院基础医学研究所 | 含氮双膦酸盐联合糖皮质激素在预防或治疗病毒性肺炎中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0275821B1 (de) | 1986-11-21 | 1992-02-26 | Ciba-Geigy Ag | Neue substituierte Alkandiphosphonsäuren |
| US7018647B1 (en) * | 1999-12-27 | 2006-03-28 | Teikoku Seiyaku Co., Ltd | Patches for external use |
| GB0029111D0 (en) | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| CA2449934A1 (en) * | 2001-06-08 | 2002-12-19 | Ortho-Mcneil Pharmaceutical, Inc. | Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| WO2003086415A1 (en) * | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| MXPA06003063A (es) * | 2003-09-19 | 2006-05-31 | Pfizer Prod Inc | Composiciones farmaceuticas y metodos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina- d y un bisfosfonato. |
| EP1758653A2 (en) * | 2004-06-17 | 2007-03-07 | Osteologix A/S | Treatments comprising strontium for rheumatic and arthritic diseases and pain |
| JP5240925B2 (ja) * | 2005-05-25 | 2013-07-17 | カロシン ファーマ， インコーポレイテッド | 変形性関節症を処置するための方法および組成物 |
| US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
| MX2009001248A (es) * | 2006-08-03 | 2009-02-11 | Nitec Pharma Ag | Tratamiento con glucocorticoide de liberacion prolongada de enfermedad reumatoide. |
| WO2010071866A2 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Combination therapy for arthritis with tranilast |
| JP5648174B2 (ja) * | 2009-05-04 | 2015-01-07 | ヌボ リサーチ インコーポレイテッド | 神経腫、神経絞扼、および他の状態と関連する疼痛を処置する方法 |
| US8946199B2 (en) | 2010-04-26 | 2015-02-03 | Ketan Desai | Co-administration of steroids and Zoledronic acid to prevent and treat side effects from Zoledronic acid infusion |
-
2013
- 2013-03-08 US US13/791,685 patent/US9012432B2/en active Active - Reinstated
-
2014
- 2014-03-07 BR BR112015021503-3A patent/BR112015021503B1/pt active IP Right Grant
- 2014-03-07 JP JP2015561747A patent/JP6839491B2/ja not_active Expired - Fee Related
- 2014-03-07 EP EP14761174.3A patent/EP2964209B1/en active Active
- 2014-03-07 WO PCT/US2014/022169 patent/WO2014138712A1/en not_active Ceased
- 2014-03-07 AU AU2014225373A patent/AU2014225373B2/en active Active
- 2014-03-07 EA EA201591638A patent/EA032067B1/ru not_active IP Right Cessation
- 2014-03-07 KR KR1020157027348A patent/KR102253394B1/ko active Active
- 2014-03-07 MX MX2015011671A patent/MX377447B/es active IP Right Grant
- 2014-03-07 CA CA2941346A patent/CA2941346C/en active Active
- 2014-03-07 ES ES14761174T patent/ES2904365T3/es active Active
- 2014-03-07 CN CN201480026349.0A patent/CN105324113B/zh active Active
-
2019
- 2019-04-03 JP JP2019071500A patent/JP2019104762A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510765A5 (enExample) | ||
| US20250295869A1 (en) | Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer | |
| US8859530B2 (en) | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis | |
| JP2021502403A5 (enExample) | ||
| JP2019521139A5 (enExample) | ||
| AU2014205529B2 (en) | Methods and compositions for treatment of demyelinating diseases | |
| RU2012134510A (ru) | Применение агента, обладающего модифицирующими свойствами в отношении гормонов надпочечников | |
| JP2012176956A5 (enExample) | ||
| JP2020517601A5 (enExample) | ||
| CA3008751C (en) | Formulations of phosphoramidate derivatives of nucleoside drugs | |
| KR102253394B1 (ko) | 골관절염의 예방 및 치료를 위한 스테로이드류 및 졸레드론산의 공투여 | |
| JP2011527345A5 (enExample) | ||
| JP2017531689A5 (enExample) | ||
| HRP20201307T1 (hr) | Upotreba reslizumaba za liječenje umjerene do ozbiljne eozinofilne astme | |
| JP2017524021A5 (enExample) | ||
| JP2014530852A5 (enExample) | ||
| JP2018522927A5 (enExample) | ||
| JP2017513809A5 (enExample) | ||
| WO2017109444A1 (en) | Combination therapy | |
| JP2010502736A5 (enExample) | ||
| JP2005516070A5 (enExample) | ||
| RU2018106498A (ru) | Производные 5-(N-конденсированный трициклический арил-тетрагидроизохинолин-6-ил) пиридин-3-ил-уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека | |
| RU2015145135A (ru) | Лечение воспалительных расстройств | |
| JP2016516762A5 (enExample) | ||
| JP2017515899A5 (enExample) |